Molecular Weight:   | 283 |
Volume:   | 225.345 |
LogP:   | -1.47 |
LogD:   | -1.01 |
LogS:   | 0.133 |
# Rotatable Bonds:   | 4 |
TPSA:   | 141.86 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 10 |
QED Drug-Likeness Score:   | 0.653 |
Synthetic Accessibility Score:   | 4.528 |
Fsp3:   | 0.286 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 1 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -6.094 |
MDCK Permeability:   | 0.001608485 |
Pgp-inhibitor:   | 0.001 |
Pgp-substrate:   | 0.002 |
Human Intestinal Absorption (HIA):   | 0.998 |
20% Bioavailability (F20%):   | 0.999 |
30% Bioavailability (F30%):   | 0.999 |
Blood-Brain-Barrier Penetration (BBB):   | 0.208 |
Plasma Protein Binding (PPB):   | 33.06% |
Volume Distribution (VD):   | 0.527 |
Pgp-substrate:   | 77.19% |
CYP1A2-inhibitor:   | 0.001 |
CYP1A2-substrate:   | 0.08 |
CYP2C19-inhibitor:   | 0.028 |
CYP2C19-substrate:   | 0.038 |
CYP2C9-inhibitor:   | 0.007 |
CYP2C9-substrate:   | 0.936 |
CYP2D6-inhibitor:   | 0.017 |
CYP2D6-substrate:   | 0.086 |
CYP3A4-inhibitor:   | 0.005 |
CYP3A4-substrate:   | 0.022 |
Clearance (CL):   | 1.131 |
Half-life (T1/2):   | 0.224 |
hERG Blockers:   | 0.03 |
Human Hepatotoxicity (H-HT):   | 0.18 |
Drug-inuced Liver Injury (DILI):   | 0.02 |
AMES Toxicity:   | 0.012 |
Rat Oral Acute Toxicity:   | 0.003 |
Maximum Recommended Daily Dose:   | 0.975 |
Skin Sensitization:   | 0.633 |
Carcinogencity:   | 0.026 |
Eye Corrosion:   | 0.215 |
Eye Irritation:   | 0.935 |
Respiratory Toxicity:   | 0.677 |
Natural Product ID:   | NPC315320 |
Common Name*:   | Risedronic Acid |
IUPAC Name:   | hydroxy-(1-hydroxy-1-phosphono-2-pyridin-1-ium-3-ylethyl)phosphinate |
Synonyms:   | Actonel; NE-58095; Risedronate; Risedronic Acid |
Standard InCHIKey:   | IIDJRNMFWXDHID-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15) |
SMILES:   | C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL923 |
PubChem CID:   |
44400168 5245 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO24859 | Concha haliotidis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO15987 | Plastrum testudinis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO13165 | Concha cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25192 | Cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO13037 | Os draconis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO23812 | Concha arcae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO560 | Os corallii | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO1985 | Caulis rubi idaei | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO13165 | Concha cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO25192 | Cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO24859 | Concha haliotidis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO3716 | Pulvis cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO19431 | Ophicalcitum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO16871 | Eriocheir sinensis seu poramon | Species | Varunidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29636 | Rhinoceros sondaicus | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO20831 | Rhinoceros sumatrensis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29693 | Rhinoceros unicornis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7937 | Os sepiae seu sepiellaezoological name | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO15987 | Plastrum testudinis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO357 | Calcitum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO328 | Plastrum testudinis praparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO560 | Os corallii | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9753 | Concha margaritifera usta | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO6651 | Cornu cervi degelatinatum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO13037 | Os draconis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO28283 | Margarita | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO15173 | Concha meretricis seu cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23812 | Concha arcae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO17349 | Colla carapacis et plastri testudinis | Species | Bombycidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO14095 | Os draconis preparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5962 | Concha arcae preparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23462 | Coridius | Species | Dinidoridae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO22587 | Herba serissae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO20831 | Rhinoceros sumatrensis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT91 | Cell Line | KB | Homo sapiens | LD50 | = | 249.0 | uM | PMID[532640] |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | Infected | = | 0.0 | % | PMID[532642] |
NPT91 | Cell Line | KB | Homo sapiens | LD50 | = | 249.0 | uM | PMID[532643] |
NPT5931 | Individual Protein | Farnesyl pyrophosphate synthase | Leishmania donovani | IC50 | = | 170.0 | nM | PMID[532643] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | = | 350000.0 | nM | PMID[532645] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 10.0 | nM | PMID[532645] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 170.0 | nM | PMID[532646] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 16.0 | nM | PMID[532646] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 169.82 | nM | PMID[532646] |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 2400.0 | nM | PMID[532648] |
NPT91 | Cell Line | KB | Homo sapiens | LD50 | = | 255.0 | uM | PMID[532648] |
NPT5931 | Individual Protein | Farnesyl pyrophosphate synthase | Leishmania donovani | Ki | = | 17.0 | nM | PMID[532649] |
NPT5932 | Individual Protein | Vacuolar-type proton translocating pyrophosphatase 1 | Trypanosoma brucei | IC50 | = | 656700.0 | nM | PMID[532650] |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 255.0 | uM | PMID[532650] |
NPT5932 | Individual Protein | Vacuolar-type proton translocating pyrophosphatase 1 | Trypanosoma brucei | TI | = | 0.4 | n.a. | PMID[532650] |
NPT5933 | Individual Protein | Hexokinase | Trypanosoma cruzi | IC50 | >= | 300000.0 | nM | PMID[532651] |
NPT5933 | Individual Protein | Hexokinase | Trypanosoma cruzi | IC50 | = | 301995.17 | nM | PMID[532651] |
NPT91 | Cell Line | KB | Homo sapiens | LD50 | = | 822.0 | uM | PMID[532651] |
NPT5931 | Individual Protein | Farnesyl pyrophosphate synthase | Leishmania donovani | IC50 | = | 170.0 | nM | PMID[532651] |
NPT5931 | Individual Protein | Farnesyl pyrophosphate synthase | Leishmania donovani | IC50 | = | 169.82 | nM | PMID[532651] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 35700.0 | nM | PMID[532652] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 43700.0 | nM | PMID[532652] |
NPT395 | Cell Line | SF-268 | Homo sapiens | IC50 | = | 23300.0 | nM | PMID[532652] |
NPT5934 | Cell Line | 13762 | Rattus norvegicus | IC50 | > | 40000.0 | nM | PMID[532652] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 452.9 | nM | PMID[532656] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 82.2 | nM | PMID[532656] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 5.7 | nM | PMID[532656] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 0.36 | nM | PMID[532656] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 5.7 | nM | PMID[532657] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | = | 57.0 | % | PMID[532659] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 300.0 | nM | PMID[532665] |
NPT65 | Cell Line | HepG2 | Homo sapiens | TC50 | = | 13.0 | mM | PMID[532668] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Ki | = | 8300000.0 | nM | PMID[532668] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | = | 300000000.0 | nM | PMID[532668] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[532669] |
NPT5935 | Individual Protein | Farnesyl diphosphate synthase | Trypanosoma cruzi | IC50 | = | 27.0 | nM | PMID[532670] |
NPT5936 | Individual Protein | Farnesyl diphosphate synthase | Toxoplasma gondii | IC50 | = | 74.0 | nM | PMID[532670] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 11.0 | nM | PMID[532673] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | > | 80.0 | % | PMID[532673] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 860.0 | nM | PMID[532673] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[532673] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio IC50 | = | 78.0 | n.a. | PMID[532673] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 11.0 | nM | PMID[532675] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Inhibition | < | 50.0 | % | PMID[532675] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 10.0 | nM | PMID[532676] |
NPT5937 | Individual Protein | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase | Aquifex aeolicus (strain VF5) | IC50 | > | 1000000.0 | nM | PMID[532677] |
NPT5935 | Individual Protein | Farnesyl diphosphate synthase | Trypanosoma cruzi | IC50 | = | 27.0 | nM | PMID[532679] |
NPT5936 | Individual Protein | Farnesyl diphosphate synthase | Toxoplasma gondii | IC50 | = | 74.0 | nM | PMID[532679] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio IC50 | <= | 2.0 | n.a. | PMID[532680] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | EC50 | = | 13000.0 | nM | PMID[532680] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 5.2 | nM | PMID[532680] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 11.0 | nM | PMID[532680] |
NPT5936 | Individual Protein | Farnesyl diphosphate synthase | Toxoplasma gondii | IC50 | = | 74.0 | nM | PMID[532681] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio | = | 0.004 | n.a. | PMID[532682] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 6.0 | nM | PMID[532682] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Delta Tm | = | 22.0 | degrees C | PMID[532682] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Delta Tm | = | 30.0 | degrees C | PMID[532682] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 11.0 | nM | PMID[532683] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 6.0 | nM | PMID[532684] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 0.36 | nM | PMID[532685] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 82.0 | nM | PMID[532685] |
NPT1495 | Individual Protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Inhibition | = | 17.0 | % | PMID[532688] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | = | 93.5 | % | PMID[532688] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 70.0 | nM | PMID[532688] |
NPT1384 | Individual Protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 10.0 | nM | PMID[532689] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 248000.0 | nM | PMID[532695] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 8600.0 | nM | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 8511.38 | nM | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 100.0 | % | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 86.49 | % | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 23.49 | % | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 19.3 | % | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 0.0 | % | PMID[532640] |
NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 4120.0 | nM | PMID[532640] |
NPT27 | Others | Unspecified | TI | = | 29.0 | n.a. | PMID[532640] | |
NPT2 | Others | Unspecified | IC50 | = | 6900.0 | nM | PMID[532641] | |
NPT2 | Others | Unspecified | IC50 | = | 6918.31 | nM | PMID[532641] | |
NPT2 | Others | Unspecified | IC50 | = | 6200.0 | nM | PMID[532641] | |
NPT2 | Others | Unspecified | IC50 | = | 6165.95 | nM | PMID[532641] | |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 8600.0 | nM | PMID[532642] |
NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | IC50 | = | 490.0 | nM | PMID[532642] |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 123000.0 | nM | PMID[532642] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 2300.0 | nM | PMID[532642] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 123000.0 | nM | PMID[532642] |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | Inhibition | = | 100.0 | % | PMID[532642] |
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 73500.0 | nM | PMID[532643] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 123000.0 | nM | PMID[532643] |
NPT27 | Others | Unspecified | TI | = | 3.46 | n.a. | PMID[532643] | |
NPT27 | Others | Unspecified | TI | = | 2.02 | n.a. | PMID[532643] | |
NPT2 | Others | Unspecified | IC50 | > | 3000000.0 | nM | PMID[532643] | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LED | = | 0.0003 | mgP kg-1 | PMID[532644] |
NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 13000.0 | nM | PMID[532644] |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 300000.0 | nM | PMID[532647] |
NPT27 | Others | Unspecified | TI | = | 106.25 | n.a. | PMID[532648] | |
NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 3000.0 | nM | PMID[532649] |
NPT2 | Others | Unspecified | EC50 | = | 5000.0 | nM | PMID[532649] | |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 300.0 | nM | PMID[532649] |
NPT27 | Others | Unspecified | Ratio LD50/IC50 | <= | 2.7 | n.a. | PMID[532651] | |
NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 3000.0 | nM | PMID[532651] |
NPT19 | Organism | Escherichia coli | Escherichia coli | IZ | = | 0.0 | mm | PMID[532653] |
NPT2 | Others | Unspecified | TIME | = | 0.1662 | hr | PMID[532654] | |
NPT27 | Others | Unspecified | IC50 | = | 31000.0 | nM | PMID[532654] | |
NPT2 | Others | Unspecified | MED | = | 12.0 | uM | PMID[532654] | |
NPT2 | Others | Unspecified | IC50 | = | 660000.0 | nM | PMID[532655] | |
NPT2 | Others | Unspecified | IC50 | = | 1584893192461.11 | nM | PMID[532655] | |
NPT2 | Others | Unspecified | IC50 | = | 90.0 | nM | PMID[532655] | |
NPT2 | Others | Unspecified | IC50 | = | 38.0 | nM | PMID[532655] | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LED | = | 0.0003 | mg kg-1 | PMID[532656] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 48.0 | % | PMID[532658] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 44.0 | % | PMID[532658] |
NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 13000.0 | nM | PMID[532659] |
NPT2 | Others | Unspecified | IC50 | = | 590.0 | nM | PMID[532660] | |
NPT2 | Others | Unspecified | IC50 | = | 630.96 | nM | PMID[532660] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 130000.0 | nM | PMID[532660] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 125892.54 | nM | PMID[532660] |
NPT605 | Organism | Homo sapiens | Homo sapiens | CL | = | 1.5 | mL.min-1.kg-1 | PMID[532661] |
NPT605 | Organism | Homo sapiens | Homo sapiens | CL_renal | = | 1.31 | mL.min-1.kg-1 | PMID[532661] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Fg | = | 1.01 | n.a. | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | CL_renal | = | 1.3 | mL.min-1.kg-1 | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | CL | = | 1.5 | mL.min-1.kg-1 | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Vdss | = | 6.3 | L.kg-1 | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | CL | = | 0.2 | mL.min-1.kg-1 | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | F_fraction | = | 0.62 | n.a. | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Fa | = | 0.62 | n.a. | PMID[532662] |
NPT614 | Tissue | Plasma | Rattus norvegicus | Fu | = | 0.76 | n.a. | PMID[532662] |
NPT605 | Organism | Homo sapiens | Homo sapiens | Fh | = | 0.99 | n.a. | PMID[532662] |
NPT2 | Others | Unspecified | LED | = | 12.0 | uM | PMID[532663] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 123000.0 | nM | PMID[532664] |
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 74000.0 | nM | PMID[532664] |
NPT27 | Others | Unspecified | MRT | = | 70.0 | hr | PMID[532666] | |
NPT27 | Others | Unspecified | T1/2 | = | 200.0 | hr | PMID[532666] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Fu | = | 0.76 | n.a. | PMID[532666] |
NPT27 | Others | Unspecified | CL | = | 1.5 | mL.min-1.kg-1 | PMID[532666] | |
NPT27 | Others | Unspecified | Vdss | = | 6.3 | L.kg-1 | PMID[532666] | |
NPT27 | Others | Unspecified | log10(%HIA +10) | = | 1.041 | n.a. | PMID[532667] | |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | IC50 | = | 16000.0 | nM | PMID[532668] |
NPT27 | Others | Unspecified | Ratio | = | 813.0 | n.a. | PMID[532668] | |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 0.5 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 1.0 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 6.0 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 4.0 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 2.5 | day | PMID[532668] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1200.0 | nM | PMID[532668] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1400.0 | nM | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 2.0 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 0.09 | % | PMID[532668] |
NPT2 | Others | Unspecified | Ki | = | 24000.0 | nM | PMID[532668] | |
NPT2 | Others | Unspecified | Ki | = | 48000.0 | nM | PMID[532668] | |
NPT2 | Others | Unspecified | Ki | = | 13000.0 | nM | PMID[532668] | |
NPT35 | Others | n.a. | LogP | = | -5.5 | n.a. | PMID[532668] | |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 8.0 | day | PMID[532668] |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 3.0 | day | PMID[532668] |
NPT2 | Others | Unspecified | IC50 | = | 1100000.0 | nM | PMID[532668] | |
NPT2 | Others | Unspecified | IC50 | = | 1700000.0 | nM | PMID[532668] | |
NPT2 | Others | Unspecified | IC50 | = | 110000.0 | nM | PMID[532668] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 16944.1 | nM | PMID[532669] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_bilirubinemia | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cholecystitis | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cholelithiasis | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cirrhosis | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_elevated liver function tests | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatic failure | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatic necrosis | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatitis | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatomegaly | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_jaundice | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver disease | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver fatty | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver function tests abnormal | = | 0.0 | n.a. | PMID[532672] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_Combined Scores | = | 0.0 | n.a. | PMID[532672] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | EC50 | = | 10000.0 | nM | PMID[532673] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | EC50 | = | 10600.0 | nM | PMID[532673] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MED | = | 0.0003 | mg kg-1 | PMID[532676] |
NPT2 | Others | Unspecified | IC50 | > | 1000000.0 | nM | PMID[532678] | |
NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | ED50 | = | 2.4 | uM | PMID[532679] |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | ED50 | = | 55.0 | uM | PMID[532679] |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | ED50 | = | 55.0 | uM | PMID[532681] |
NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | ED50 | = | 2.4 | uM | PMID[532681] |
NPT2 | Others | Unspecified | IC50 | = | 27.0 | nM | PMID[532681] | |
NPT27 | Others | Unspecified | Activity | = | 60.0 | % | PMID[532682] | |
NPT2 | Others | Unspecified | IC50 | = | 300.0 | nM | PMID[532685] | |
NPT605 | Organism | Homo sapiens | Homo sapiens | DILI_severity_class | = | 3.0 | n.a. | PMID[532687] |
NPT23182 | MACROMOLECULE | Hydroxyapatite | Homo sapiens | Activity | = | 87.0 | % | PMID[532688] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -4.82 | % | PMID[532690] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.02 | % | PMID[532691] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[532692] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[532692] |
NPT26693 | SINGLE PROTEIN | Butyrophilin subfamily 3 member A1 | Homo sapiens | EC50 | = | 80.0 | nM | PMID[532693] |
NPT23196 | SINGLE PROTEIN | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | Homo sapiens | Activity | = | 17.4 | % | PMID[532696] |
NPT23196 | SINGLE PROTEIN | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | Homo sapiens | Activity | = | 82.7 | % | PMID[532696] |
NPT27367 | SINGLE PROTEIN | Farnesyl pyrophosphate synthase | Leishmania major | Ki | = | 16.0 | nM | PMID[532694] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC315320 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8507 | High Similarity | NPC322488 |
0.8296 | Intermediate Similarity | NPC324611 |
0.8271 | Intermediate Similarity | NPC471313 |
0.8271 | Intermediate Similarity | NPC471311 |
0.8271 | Intermediate Similarity | NPC212125 |
0.8226 | Intermediate Similarity | NPC27802 |
0.8134 | Intermediate Similarity | NPC165370 |
0.8134 | Intermediate Similarity | NPC306397 |
0.7984 | Intermediate Similarity | NPC76540 |
0.7929 | Intermediate Similarity | NPC29702 |
0.7786 | Intermediate Similarity | NPC297486 |
0.7786 | Intermediate Similarity | NPC471402 |
0.7786 | Intermediate Similarity | NPC240136 |
0.7746 | Intermediate Similarity | NPC114310 |
0.7746 | Intermediate Similarity | NPC471312 |
0.7727 | Intermediate Similarity | NPC91958 |
0.7704 | Intermediate Similarity | NPC290094 |
0.7674 | Intermediate Similarity | NPC235843 |
0.7643 | Intermediate Similarity | NPC256893 |
0.7642 | Intermediate Similarity | NPC83987 |
0.7594 | Intermediate Similarity | NPC143603 |
0.7591 | Intermediate Similarity | NPC151489 |
0.7556 | Intermediate Similarity | NPC182570 |
0.7556 | Intermediate Similarity | NPC48564 |
0.7556 | Intermediate Similarity | NPC265605 |
0.7552 | Intermediate Similarity | NPC328029 |
0.7551 | Intermediate Similarity | NPC471323 |
0.7536 | Intermediate Similarity | NPC169625 |
0.7536 | Intermediate Similarity | NPC202957 |
0.7516 | Intermediate Similarity | NPC319456 |
0.7429 | Intermediate Similarity | NPC89490 |
0.7422 | Intermediate Similarity | NPC231655 |
0.7394 | Intermediate Similarity | NPC471322 |
0.7391 | Intermediate Similarity | NPC27740 |
0.7391 | Intermediate Similarity | NPC476322 |
0.7383 | Intermediate Similarity | NPC167400 |
0.7376 | Intermediate Similarity | NPC329896 |
0.7376 | Intermediate Similarity | NPC475090 |
0.7376 | Intermediate Similarity | NPC475105 |
0.7338 | Intermediate Similarity | NPC166424 |
0.7338 | Intermediate Similarity | NPC146373 |
0.7338 | Intermediate Similarity | NPC245244 |
0.7325 | Intermediate Similarity | NPC211187 |
0.7319 | Intermediate Similarity | NPC46358 |
0.729 | Intermediate Similarity | NPC138018 |
0.7273 | Intermediate Similarity | NPC174421 |
0.7261 | Intermediate Similarity | NPC71079 |
0.7234 | Intermediate Similarity | NPC278451 |
0.7215 | Intermediate Similarity | NPC473057 |
0.7215 | Intermediate Similarity | NPC474217 |
0.7183 | Intermediate Similarity | NPC471589 |
0.717 | Intermediate Similarity | NPC85918 |
0.717 | Intermediate Similarity | NPC471178 |
0.7152 | Intermediate Similarity | NPC59779 |
0.7152 | Intermediate Similarity | NPC471177 |
0.7152 | Intermediate Similarity | NPC124542 |
0.7143 | Intermediate Similarity | NPC256828 |
0.7143 | Intermediate Similarity | NPC65408 |
0.7134 | Intermediate Similarity | NPC230869 |
0.7133 | Intermediate Similarity | NPC476131 |
0.7125 | Intermediate Similarity | NPC41717 |
0.7125 | Intermediate Similarity | NPC278366 |
0.7125 | Intermediate Similarity | NPC127730 |
0.7122 | Intermediate Similarity | NPC329825 |
0.7114 | Intermediate Similarity | NPC318935 |
0.7107 | Intermediate Similarity | NPC97367 |
0.7105 | Intermediate Similarity | NPC220523 |
0.7097 | Intermediate Similarity | NPC312860 |
0.7089 | Intermediate Similarity | NPC131718 |
0.7086 | Intermediate Similarity | NPC230085 |
0.7086 | Intermediate Similarity | NPC159630 |
0.7083 | Intermediate Similarity | NPC282398 |
0.7083 | Intermediate Similarity | NPC69914 |
0.707 | Intermediate Similarity | NPC129721 |
0.7051 | Intermediate Similarity | NPC263455 |
0.7034 | Intermediate Similarity | NPC101165 |
0.7019 | Intermediate Similarity | NPC108469 |
0.7 | Intermediate Similarity | NPC102423 |
0.6994 | Remote Similarity | NPC273532 |
0.6993 | Remote Similarity | NPC302159 |
0.6987 | Remote Similarity | NPC469765 |
0.6987 | Remote Similarity | NPC259644 |
0.6987 | Remote Similarity | NPC73952 |
0.6987 | Remote Similarity | NPC25008 |
0.6987 | Remote Similarity | NPC469763 |
0.6987 | Remote Similarity | NPC469760 |
0.6987 | Remote Similarity | NPC469786 |
0.6986 | Remote Similarity | NPC330326 |
0.6963 | Remote Similarity | NPC473901 |
0.6962 | Remote Similarity | NPC469762 |
0.6957 | Remote Similarity | NPC477975 |
0.6948 | Remote Similarity | NPC112741 |
0.6943 | Remote Similarity | NPC75540 |
0.6943 | Remote Similarity | NPC63562 |
0.6943 | Remote Similarity | NPC80597 |
0.6943 | Remote Similarity | NPC70922 |
0.6943 | Remote Similarity | NPC212376 |
0.6943 | Remote Similarity | NPC211572 |
0.6928 | Remote Similarity | NPC314372 |
0.6918 | Remote Similarity | NPC113812 |
0.6914 | Remote Similarity | NPC98187 |
0.6908 | Remote Similarity | NPC190296 |
0.6899 | Remote Similarity | NPC469785 |
0.6894 | Remote Similarity | NPC311276 |
0.6879 | Remote Similarity | NPC107287 |
0.6875 | Remote Similarity | NPC279918 |
0.6867 | Remote Similarity | NPC150048 |
0.6867 | Remote Similarity | NPC203754 |
0.6861 | Remote Similarity | NPC84268 |
0.6855 | Remote Similarity | NPC212742 |
0.6855 | Remote Similarity | NPC269919 |
0.6855 | Remote Similarity | NPC132680 |
0.6845 | Remote Similarity | NPC471997 |
0.6839 | Remote Similarity | NPC477974 |
0.6832 | Remote Similarity | NPC282231 |
0.6829 | Remote Similarity | NPC314940 |
0.6829 | Remote Similarity | NPC473764 |
0.6818 | Remote Similarity | NPC159856 |
0.681 | Remote Similarity | NPC160105 |
0.68 | Remote Similarity | NPC314102 |
0.68 | Remote Similarity | NPC251722 |
0.679 | Remote Similarity | NPC40779 |
0.679 | Remote Similarity | NPC78375 |
0.679 | Remote Similarity | NPC476446 |
0.679 | Remote Similarity | NPC469813 |
0.6786 | Remote Similarity | NPC11863 |
0.677 | Remote Similarity | NPC63338 |
0.677 | Remote Similarity | NPC324203 |
0.677 | Remote Similarity | NPC322976 |
0.677 | Remote Similarity | NPC25899 |
0.6765 | Remote Similarity | NPC322043 |
0.6761 | Remote Similarity | NPC56856 |
0.6755 | Remote Similarity | NPC169433 |
0.6747 | Remote Similarity | NPC313791 |
0.6747 | Remote Similarity | NPC477976 |
0.6731 | Remote Similarity | NPC105811 |
0.673 | Remote Similarity | NPC209362 |
0.6728 | Remote Similarity | NPC48192 |
0.6726 | Remote Similarity | NPC111275 |
0.6712 | Remote Similarity | NPC313823 |
0.6711 | Remote Similarity | NPC32002 |
0.6711 | Remote Similarity | NPC316811 |
0.6711 | Remote Similarity | NPC315348 |
0.671 | Remote Similarity | NPC467188 |
0.6707 | Remote Similarity | NPC474561 |
0.6707 | Remote Similarity | NPC54988 |
0.6707 | Remote Similarity | NPC49954 |
0.669 | Remote Similarity | NPC135488 |
0.6689 | Remote Similarity | NPC82295 |
0.6687 | Remote Similarity | NPC252590 |
0.6687 | Remote Similarity | NPC162268 |
0.6687 | Remote Similarity | NPC263439 |
0.6686 | Remote Similarity | NPC62510 |
0.6667 | Remote Similarity | NPC78020 |
0.6667 | Remote Similarity | NPC63751 |
0.6667 | Remote Similarity | NPC327373 |
0.6667 | Remote Similarity | NPC213774 |
0.6667 | Remote Similarity | NPC325093 |
0.6667 | Remote Similarity | NPC161292 |
0.6647 | Remote Similarity | NPC317010 |
0.6647 | Remote Similarity | NPC314603 |
0.6646 | Remote Similarity | NPC213914 |
0.6646 | Remote Similarity | NPC24678 |
0.6646 | Remote Similarity | NPC105818 |
0.6628 | Remote Similarity | NPC207851 |
0.6624 | Remote Similarity | NPC470111 |
0.6624 | Remote Similarity | NPC471957 |
0.6623 | Remote Similarity | NPC29886 |
0.6623 | Remote Similarity | NPC261195 |
0.6623 | Remote Similarity | NPC60553 |
0.6623 | Remote Similarity | NPC476454 |
0.6623 | Remote Similarity | NPC96102 |
0.661 | Remote Similarity | NPC106937 |
0.6609 | Remote Similarity | NPC36498 |
0.6609 | Remote Similarity | NPC325775 |
0.6608 | Remote Similarity | NPC71037 |
0.6607 | Remote Similarity | NPC469938 |
0.6604 | Remote Similarity | NPC70406 |
0.659 | Remote Similarity | NPC318020 |
0.6588 | Remote Similarity | NPC248462 |
0.6585 | Remote Similarity | NPC194640 |
0.6582 | Remote Similarity | NPC288445 |
0.6579 | Remote Similarity | NPC150259 |
0.6579 | Remote Similarity | NPC105127 |
0.6579 | Remote Similarity | NPC84911 |
0.6571 | Remote Similarity | NPC148140 |
0.657 | Remote Similarity | NPC48938 |
0.6566 | Remote Similarity | NPC201700 |
0.6529 | Remote Similarity | NPC184964 |
0.6525 | Remote Similarity | NPC81561 |
0.6514 | Remote Similarity | NPC328798 |
0.6509 | Remote Similarity | NPC149155 |
0.6509 | Remote Similarity | NPC139763 |
0.6509 | Remote Similarity | NPC110500 |
0.6509 | Remote Similarity | NPC203468 |
0.65 | Remote Similarity | NPC216713 |
0.65 | Remote Similarity | NPC153769 |
0.6497 | Remote Similarity | NPC86288 |
0.6497 | Remote Similarity | NPC114974 |
0.6497 | Remote Similarity | NPC285731 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC315320 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9206 | Approved |
1.0 | High Similarity | NPD9207 | Approved |
0.8271 | Intermediate Similarity | NPD9284 | Approved |
0.8134 | Intermediate Similarity | NPD9080 | Approved |
0.8 | Intermediate Similarity | NPD9506 | Approved |
0.7943 | Intermediate Similarity | NPD2896 | Discontinued |
0.7943 | Intermediate Similarity | NPD203 | Clinical (unspecified phase) |
0.7755 | Intermediate Similarity | NPD4703 | Approved |
0.7755 | Intermediate Similarity | NPD4702 | Approved |
0.7724 | Intermediate Similarity | NPD3717 | Discontinued |
0.7708 | Intermediate Similarity | NPD1649 | Discontinued |
0.7681 | Intermediate Similarity | NPD1095 | Clinical (unspecified phase) |
0.7671 | Intermediate Similarity | NPD3813 | Approved |
0.7671 | Intermediate Similarity | NPD1352 | Discontinued |
0.7671 | Intermediate Similarity | NPD751 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD269 | Clinical (unspecified phase) |
0.7568 | Intermediate Similarity | NPD6148 | Clinical (unspecified phase) |
0.7556 | Intermediate Similarity | NPD271 | Approved |
0.7556 | Intermediate Similarity | NPD268 | Approved |
0.7556 | Intermediate Similarity | NPD270 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3262 | Approved |
0.7465 | Intermediate Similarity | NPD1627 | Clinical (unspecified phase) |
0.7422 | Intermediate Similarity | NPD9099 | Clinical (unspecified phase) |
0.7422 | Intermediate Similarity | NPD9098 | Phase 3 |
0.74 | Intermediate Similarity | NPD1661 | Suspended |
0.7391 | Intermediate Similarity | NPD9357 | Approved |
0.7383 | Intermediate Similarity | NPD9074 | Approved |
0.7383 | Intermediate Similarity | NPD9075 | Approved |
0.7355 | Intermediate Similarity | NPD5255 | Approved |
0.7308 | Intermediate Similarity | NPD2511 | Approved |
0.7286 | Intermediate Similarity | NPD9583 | Approved |
0.7273 | Intermediate Similarity | NPD4824 | Approved |
0.7273 | Intermediate Similarity | NPD4823 | Approved |
0.7273 | Intermediate Similarity | NPD9726 | Discontinued |
0.7234 | Intermediate Similarity | NPD2118 | Approved |
0.7234 | Intermediate Similarity | NPD992 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD2119 | Approved |
0.7234 | Intermediate Similarity | NPD991 | Phase 2 |
0.7234 | Intermediate Similarity | NPD1598 | Discontinued |
0.723 | Intermediate Similarity | NPD107 | Approved |
0.7226 | Intermediate Similarity | NPD6026 | Approved |
0.7215 | Intermediate Similarity | NPD5088 | Discontinued |
0.7211 | Intermediate Similarity | NPD1380 | Discovery |
0.7211 | Intermediate Similarity | NPD9076 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD2809 | Approved |
0.7152 | Intermediate Similarity | NPD8026 | Phase 1 |
0.7143 | Intermediate Similarity | NPD9706 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD200 | Phase 2 |
0.7143 | Intermediate Similarity | NPD201 | Phase 2 |
0.7118 | Intermediate Similarity | NPD2544 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD8129 | Discovery |
0.7097 | Intermediate Similarity | NPD2012 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD8037 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD8036 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD3475 | Approved |
0.7083 | Intermediate Similarity | NPD3476 | Approved |
0.7081 | Intermediate Similarity | NPD9582 | Phase 3 |
0.7081 | Intermediate Similarity | NPD5862 | Discovery |
0.707 | Intermediate Similarity | NPD5541 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD1382 | Phase 2 |
0.7067 | Intermediate Similarity | NPD1383 | Phase 3 |
0.7063 | Intermediate Similarity | NPD925 | Approved |
0.7063 | Intermediate Similarity | NPD926 | Approved |
0.7051 | Intermediate Similarity | NPD5358 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD704 | Clinical (unspecified phase) |
0.702 | Intermediate Similarity | NPD1427 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD424 | Approved |
0.7019 | Intermediate Similarity | NPD425 | Approved |
0.7007 | Intermediate Similarity | NPD272 | Approved |
0.7007 | Intermediate Similarity | NPD9396 | Approved |
0.7007 | Intermediate Similarity | NPD9392 | Approved |
0.7 | Intermediate Similarity | NPD748 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD7469 | Discontinued |
0.6986 | Remote Similarity | NPD1995 | Approved |
0.6986 | Remote Similarity | NPD1993 | Approved |
0.6986 | Remote Similarity | NPD1994 | Approved |
0.6986 | Remote Similarity | NPD9100 | Approved |
0.6985 | Remote Similarity | NPD60 | Approved |
0.6975 | Remote Similarity | NPD6872 | Clinical (unspecified phase) |
0.6975 | Remote Similarity | NPD2781 | Approved |
0.6966 | Remote Similarity | NPD715 | Phase 3 |
0.6962 | Remote Similarity | NPD2581 | Approved |
0.6962 | Remote Similarity | NPD2582 | Approved |
0.6959 | Remote Similarity | NPD206 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD792 | Discontinued |
0.6957 | Remote Similarity | NPD2782 | Approved |
0.6957 | Remote Similarity | NPD2780 | Approved |
0.6954 | Remote Similarity | NPD4805 | Approved |
0.6948 | Remote Similarity | NPD9271 | Approved |
0.6948 | Remote Similarity | NPD2089 | Clinical (unspecified phase) |
0.6943 | Remote Similarity | NPD2061 | Approved |
0.6939 | Remote Similarity | NPD4030 | Approved |
0.6939 | Remote Similarity | NPD4028 | Approved |
0.6939 | Remote Similarity | NPD3942 | Approved |
0.6939 | Remote Similarity | NPD4029 | Approved |
0.6939 | Remote Similarity | NPD3944 | Approved |
0.6937 | Remote Similarity | NPD4239 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD5965 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD510 | Phase 1 |
0.6903 | Remote Similarity | NPD1183 | Approved |
0.6892 | Remote Similarity | NPD2140 | Approved |
0.6892 | Remote Similarity | NPD2142 | Approved |
0.6892 | Remote Similarity | NPD2141 | Approved |
0.689 | Remote Similarity | NPD5934 | Clinical (unspecified phase) |
0.6884 | Remote Similarity | NPD8840 | Approved |
0.6867 | Remote Similarity | NPD5100 | Phase 3 |
0.6855 | Remote Similarity | NPD9382 | Approved |
0.6855 | Remote Similarity | NPD9383 | Approved |
0.6829 | Remote Similarity | NPD2620 | Phase 2 |
0.6829 | Remote Similarity | NPD2619 | Clinical (unspecified phase) |
0.6826 | Remote Similarity | NPD5751 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD4804 | Approved |
0.681 | Remote Similarity | NPD5611 | Phase 2 |
0.6807 | Remote Similarity | NPD5065 | Approved |
0.6807 | Remote Similarity | NPD5322 | Clinical (unspecified phase) |
0.6805 | Remote Similarity | NPD1570 | Approved |
0.6805 | Remote Similarity | NPD1783 | Clinical (unspecified phase) |
0.6803 | Remote Similarity | NPD803 | Phase 1 |
0.6795 | Remote Similarity | NPD3576 | Approved |
0.6795 | Remote Similarity | NPD3575 | Approved |
0.679 | Remote Similarity | NPD6635 | Approved |
0.6786 | Remote Similarity | NPD1620 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD9599 | Approved |
0.6776 | Remote Similarity | NPD1395 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD112 | Approved |
0.677 | Remote Similarity | NPD9705 | Discontinued |
0.677 | Remote Similarity | NPD9398 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD820 | Phase 3 |
0.6731 | Remote Similarity | NPD1270 | Approved |
0.6727 | Remote Similarity | NPD4184 | Clinical (unspecified phase) |
0.6726 | Remote Similarity | NPD8123 | Approved |
0.6726 | Remote Similarity | NPD8122 | Approved |
0.6725 | Remote Similarity | NPD1096 | Discontinued |
0.6712 | Remote Similarity | NPD5352 | Clinical (unspecified phase) |
0.6711 | Remote Similarity | NPD2072 | Approved |
0.6711 | Remote Similarity | NPD2073 | Approved |
0.6711 | Remote Similarity | NPD2069 | Approved |
0.6711 | Remote Similarity | NPD2070 | Approved |
0.6711 | Remote Similarity | NPD2071 | Approved |
0.6711 | Remote Similarity | NPD2075 | Approved |
0.6711 | Remote Similarity | NPD768 | Clinical (unspecified phase) |
0.6711 | Remote Similarity | NPD2074 | Approved |
0.6711 | Remote Similarity | NPD2068 | Approved |
0.6709 | Remote Similarity | NPD6476 | Clinical (unspecified phase) |
0.6709 | Remote Similarity | NPD2882 | Phase 1 |
0.6709 | Remote Similarity | NPD6158 | Phase 2 |
0.6708 | Remote Similarity | NPD604 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD9690 | Approved |
0.6707 | Remote Similarity | NPD4174 | Clinical (unspecified phase) |
0.6706 | Remote Similarity | NPD7414 | Clinical (unspecified phase) |
0.669 | Remote Similarity | NPD9598 | Discontinued |
0.6687 | Remote Similarity | NPD5925 | Phase 1 |
0.6647 | Remote Similarity | NPD1599 | Approved |
0.6646 | Remote Similarity | NPD4671 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD4669 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD4670 | Clinical (unspecified phase) |
0.6623 | Remote Similarity | NPD1722 | Approved |
0.6623 | Remote Similarity | NPD1592 | Phase 3 |
0.6623 | Remote Similarity | NPD198 | Clinical (unspecified phase) |
0.661 | Remote Similarity | NPD802 | Phase 2 |
0.6609 | Remote Similarity | NPD8021 | Approved |
0.6609 | Remote Similarity | NPD9363 | Approved |
0.6609 | Remote Similarity | NPD8020 | Approved |
0.6609 | Remote Similarity | NPD9364 | Phase 2 |
0.6608 | Remote Similarity | NPD8408 | Discontinued |
0.6608 | Remote Similarity | NPD9362 | Approved |
0.6607 | Remote Similarity | NPD1923 | Clinical (unspecified phase) |
0.6603 | Remote Similarity | NPD175 | Clinical (unspecified phase) |
0.6601 | Remote Similarity | NPD945 | Clinical (unspecified phase) |
0.659 | Remote Similarity | NPD6241 | Phase 1 |
0.659 | Remote Similarity | NPD3082 | Discontinued |
0.6584 | Remote Similarity | NPD2748 | Clinical (unspecified phase) |
0.6584 | Remote Similarity | NPD276 | Clinical (unspecified phase) |
0.6581 | Remote Similarity | NPD4510 | Discontinued |
0.6581 | Remote Similarity | NPD2006 | Phase 2 |
0.6581 | Remote Similarity | NPD2007 | Clinical (unspecified phase) |
0.657 | Remote Similarity | NPD5728 | Clinical (unspecified phase) |
0.657 | Remote Similarity | NPD5213 | Clinical (unspecified phase) |
0.6568 | Remote Similarity | NPD6375 | Clinical (unspecified phase) |
0.6566 | Remote Similarity | NPD4640 | Approved |
0.6566 | Remote Similarity | NPD4638 | Approved |
0.6566 | Remote Similarity | NPD4639 | Approved |
0.6564 | Remote Similarity | NPD687 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD5317 | Clinical (unspecified phase) |
0.6552 | Remote Similarity | NPD3039 | Clinical (unspecified phase) |
0.6552 | Remote Similarity | NPD4375 | Approved |
0.6548 | Remote Similarity | NPD750 | Phase 2 |
0.6548 | Remote Similarity | NPD2076 | Approved |
0.6548 | Remote Similarity | NPD2077 | Approved |
0.6545 | Remote Similarity | NPD1568 | Clinical (unspecified phase) |
0.6545 | Remote Similarity | NPD2719 | Clinical (unspecified phase) |
0.6545 | Remote Similarity | NPD2720 | Phase 1 |
0.6538 | Remote Similarity | NPD1918 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD8823 | Approved |
0.6536 | Remote Similarity | NPD2323 | Clinical (unspecified phase) |
0.6534 | Remote Similarity | NPD8063 | Discontinued |
0.6529 | Remote Similarity | NPD1032 | Phase 2 |
0.6516 | Remote Similarity | NPD5020 | Approved |
0.6509 | Remote Similarity | NPD2928 | Phase 2 |
0.6509 | Remote Similarity | NPD482 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.